Medicare Enrolled

Dr. Andrew Antoszyk, MD

Retina Specialist (Ophthalmology) Physician · Charlotte, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
6035 FAIRVIEW RD, Charlotte, NC 28210
7042953000
In practice since 2006 (20 years)
NPI: 1427016443 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Antoszyk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Antoszyk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Antoszyk

Dr. Andrew Antoszyk is a retina specialist physician in Charlotte, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Antoszyk performed 2,084 Medicare services across 1,077 unique beneficiaries.

Between the years covered by Open Payments, Dr. Antoszyk received a total of $9,173 from 15 pharmaceutical and/or device companies across 61 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Antoszyk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 2,084 Medicare services $9,173 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,084
Medicare services
Bottom 14% in NC for retina specialist (ophthalmology) physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,077
Unique beneficiaries
$269
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~104 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Aflibercept eye injection (Eylea) 664 $678 $1,100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 438 $86 $252
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
 437 $28 $79
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
 348 $90 $353
Injection, brolucizumab-dbll, 1 mg 102 $235 $444
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
 84 $40 $260
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
 11 $94 $206
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$9,173
Total received (2018-2022)
Avg $1,835/year across 5 years
Top 23% in NC for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
61
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,094 (55.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,504 (27.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,575 (17.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$659
2021
$273
2020
$1,626
2019
$2,498
2018
$4,117

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Notal Vision, Inc.
$568
Apellis Pharmaceuticals, Inc.
$34
Genentech USA, Inc.
$21
ABBVIE INC.
$20
Alimera Sciences, Inc.
$16
Top 3 companies account for 94.6% of 2022 payments
All-time payments by company (2018-2022) ›
Genentech, Inc.
$3,481
F. Hoffmann-La Roche AG
$1,936
Cardinal Health 108 LLC
$1,575
Novartis Pharmaceuticals Corporation
$826
Notal Vision, Inc.
$568
Genentech USA, Inc.
$350
Regeneron Healthcare Solutions, Inc.
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$92
Allergan Inc.
$66
Alimera Sciences, Inc.
$35
Apellis Pharmaceuticals, Inc.
$34
Bausch & Lomb, a division of Bausch Health US, LLC
$33
Carl Zeiss Meditec USA, Inc.
$21
ABBVIE INC.
$20
Spark Therapeutics, Inc.
$14
Top 3 companies account for 76.2% of all-time payments
Associated products mentioned in payments ›
BEOVU · CLARUS 700 · EYLEA · ILUVIEN · LUXTURNA · Lucentis · Non-Covered Product · OZURDEX · SUSVIMO · VABYSMO · VISUDYNE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a retina specialist physician in Charlotte?
Compare retina specialist physicians in the Charlotte area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
9
Per 100K population
0.8
County median income
$83,765
Nearest hospital
ATRIUM HEALTH PINEVILLE
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Antoszyk is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Antoszyk experienced with aflibercept eye injection (eylea)?
Based on Medicare claims data, Dr. Antoszyk performed 664 aflibercept eye injection (eylea) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Antoszyk receive payments from pharmaceutical companies?
Yes. Dr. Antoszyk received a total of $9,173 from 15 companies across 61 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Antoszyk's costs compare to other retina specialist physicians in Charlotte?
Dr. Antoszyk's average Medicare payment per service is $269. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Antoszyk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Retina Specialist Physicians in Charlotte
Browse retina specialist physicians in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Retina Specialist Physicians in NC
Retina specialist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Retina Specialist Physicians in NC
Which NC retina specialist physicians receive the most from drug and device companies.
By company
Genentech, Inc. Payments to Doctors
See all physicians who received payments from Genentech, Inc.
By company
F. Hoffmann-La Roche AG Payments to Doctors
See all physicians who received payments from F. Hoffmann-La Roche AG.
By company
Cardinal Health 108 LLC Payments to Doctors
See all physicians who received payments from Cardinal Health 108 LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →